Global Tissue Diagnostics Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
The global tissue diagnostics market is expected to reach $4811.9 million by 2022 growing at 8.6% CAGR during 2016-2022. In regional outlook, market is divided into North America, Europe, Asia Pacific and rest of the world. North America dominates the global tissue diagnostics market, which accounts for around 40.7% of the global market share. The major reason boosting the North American region upward is the rising patient’s awareness level, presence of technologically advanced products, and the rising healthcare expenditure. The United States and Canada are the major countries in North American region that boost the market growth. Asia Pacific is the fastest growing global tissue diagnostics market, due to rapid improvement in healthcare infrastructure, presence of sophisticated healthcare facilities in the developed markets of Australia and Japan. Asia Pacific is one of the most profitable and revenue generating market for major market players in the forecast period. China, Japan, South Korea and Australia are the major countries in Asia Pacific region. Europe is showing positive growth due to rising prevalence of cancer in this region, favorable government policies related to tissue diagnostics and increasing geriatric population. Rest of the world is showing positive growth rate for the global tissue diagnostics market in the forecast period. Brazil and Middle East is the major countries in the Rest of the world region.
Global tissue diagnostics market is segmented on the basis of technology, disease, products, end users and regional outlook. In technology segment, market is divided into immunohistochemistry, in situ hybridization, digital pathology and workflow management, magneto encephalograph and special staining. In disease segment, market is divided into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung carcinoma and other disease. In product segment, market is divided into instrument and consumables. In end user segment, market is divided into hospitals, pharmaceuticals, research laboratories, contract research organization and others.
Global tissue diagnostics market is rising rapidly and is demanding for effective tissue diagnostic procedures majorly due to increasing prevalence of chronic diseases, such as liver cancer, brain cancer, lung cancer, colorectal, breast cancer, cervical cancers, cardiovascular disorders, malaria, and diabetes and many more. Apart from this, the increased use of biomarkers for disease diagnosis has a positive impact on the market for global tissue diagnostics in the forecast period. Biomarkers help to evaluate the physiological, pharmacological and disease processes, and are broadly used for various clinical studies in the area of genomics, proteomics, metabolomics and transcriptomics. The ability of biomarkers to aid in the purpose of disease prognosis, elucidation of pathways is majorly affected by the disease and identification of individuals which is likely to respond to specific therapeutic interventions, which will result in its better utilization during the forecast period.
Some of the major market players are Danaher corporation, Medtronic Inc., GE healthcare, Ventana medical Systems, Thermo fisher scientific, Asuragen Inc., Johnson & Johnson, Span Diagnostics, Cadwell laboratories Inc., veridex, Xcyton diagnostic, Sekisui diagnostic, etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.